Ohcanbohtosat - Christopher Tretter
- Čájehuvvo 1 - 1 / 1
-
1
Neoadjuvant Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin With Pegfilgrastim Support in Muscle-Invasive Urothelial Cancer: Pathologic, Radiologic, and Biomarker... Dahkki Toni K. Choueiri, Susanna Jacobus, Joaquim Bellmunt, Angela Qu, Leonard J. Appleman, Christopher Tretter, Glenn J. Bubley, Edward C. Stack, Sabina Signoretti, Meghara Walsh, Graeme S. Steele, Michelle S. Hirsch, Christopher J. Sweeney, Mary-Ellen Taplin, Adam S. Kibel, Katherine M. Krajewski, Philip W. Kantoff, Robert W. Ross, Jonathan E. Rosenberg
Almmustuhtton 2014Artigo
Ohcanreaiddut:
Laktáseaddji fáttát
Biochemistry
Biomarker
Bladder cancer
Cancer
Chemistry
Chemotherapy
Cisplatin
Clinical endpoint
Clinical trial
Confidence interval
Cystectomy
DNA repair
ERCC1
Febrile neutropenia
Gene
Hazard ratio
Internal medicine
Medicine
Methotrexate
Neutropenia
Nucleotide excision repair
Oncology
Pegfilgrastim
Regimen
Urology
Vinblastine